Association of low prostate-specific antigen concentration and panhypopituitarism

Andjela Drincic, Robert J. Anderson, Richard Baltaro

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Objective: To report the association of undetectable or very low prostate-specific antigen (PSA) concentrations with hypopituitarism. Methods: We present a case series of 4 patients with low or undetectable PSA concentrations and associated panhypopituitarism and summarize the clinical presentation and pertinent laboratory and radiologic findings. We review related literature and discuss possible mechanisms explaining the described association. Results: Four men with PSA values below the second percentile of a healthy population had hypopituitarism. In 3 men, low PSA concentrations were noted before large pituitary tumors were diagnosed. No man had headaches, visual problems, or other symptoms that were severe enough to prompt a search for tumor. All 4 patients had undetectable total testosterone levels. Luteinizing hormone and follicle-stimulating hormone levels were low to low-normal in 3 of the 4 patients. Baseline growth hormone level was low in 1 patient and undetectable in the other 3. The insulinlike growth factor 1 concentration was less than 73 ng/mL in each patient. Conclusions: We believe that the association of low PSA concentrations and hypopituitarism is not incidental and that the extremely low PSA values in this case series were a consequence of both gonadal and growth hormone deficiency. We suggest that low PSA is a marker of combined profound testosterone and growth hormone deficiency in men with panhypopituitarism. This marker is important because PSA is frequently measured during routine health care visits; a low concentration may be the first clue to the presence of hypopituitarism in an otherwise asymptomatic patient.

Original languageEnglish
Pages (from-to)432-436
Number of pages5
JournalEndocrine Practice
Volume14
Issue number4
StatePublished - May 2008

Fingerprint

Prostate-Specific Antigen
Hypopituitarism
Growth Hormone
Testosterone
Gonadal Hormones
Combined Pituitary Hormone Deficiency
Follicle Stimulating Hormone
Pituitary Neoplasms
Luteinizing Hormone
Headache
Intercellular Signaling Peptides and Proteins
Delivery of Health Care
Population
Neoplasms

All Science Journal Classification (ASJC) codes

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Medicine(all)

Cite this

Association of low prostate-specific antigen concentration and panhypopituitarism. / Drincic, Andjela; Anderson, Robert J.; Baltaro, Richard.

In: Endocrine Practice, Vol. 14, No. 4, 05.2008, p. 432-436.

Research output: Contribution to journalArticle

Drincic, Andjela ; Anderson, Robert J. ; Baltaro, Richard. / Association of low prostate-specific antigen concentration and panhypopituitarism. In: Endocrine Practice. 2008 ; Vol. 14, No. 4. pp. 432-436.
@article{4b01ef76b6de43c2b40a0acc0f585032,
title = "Association of low prostate-specific antigen concentration and panhypopituitarism",
abstract = "Objective: To report the association of undetectable or very low prostate-specific antigen (PSA) concentrations with hypopituitarism. Methods: We present a case series of 4 patients with low or undetectable PSA concentrations and associated panhypopituitarism and summarize the clinical presentation and pertinent laboratory and radiologic findings. We review related literature and discuss possible mechanisms explaining the described association. Results: Four men with PSA values below the second percentile of a healthy population had hypopituitarism. In 3 men, low PSA concentrations were noted before large pituitary tumors were diagnosed. No man had headaches, visual problems, or other symptoms that were severe enough to prompt a search for tumor. All 4 patients had undetectable total testosterone levels. Luteinizing hormone and follicle-stimulating hormone levels were low to low-normal in 3 of the 4 patients. Baseline growth hormone level was low in 1 patient and undetectable in the other 3. The insulinlike growth factor 1 concentration was less than 73 ng/mL in each patient. Conclusions: We believe that the association of low PSA concentrations and hypopituitarism is not incidental and that the extremely low PSA values in this case series were a consequence of both gonadal and growth hormone deficiency. We suggest that low PSA is a marker of combined profound testosterone and growth hormone deficiency in men with panhypopituitarism. This marker is important because PSA is frequently measured during routine health care visits; a low concentration may be the first clue to the presence of hypopituitarism in an otherwise asymptomatic patient.",
author = "Andjela Drincic and Anderson, {Robert J.} and Richard Baltaro",
year = "2008",
month = "5",
language = "English",
volume = "14",
pages = "432--436",
journal = "Endocrine Practice",
issn = "1530-891X",
publisher = "American Association of Clinical Endocrinology",
number = "4",

}

TY - JOUR

T1 - Association of low prostate-specific antigen concentration and panhypopituitarism

AU - Drincic, Andjela

AU - Anderson, Robert J.

AU - Baltaro, Richard

PY - 2008/5

Y1 - 2008/5

N2 - Objective: To report the association of undetectable or very low prostate-specific antigen (PSA) concentrations with hypopituitarism. Methods: We present a case series of 4 patients with low or undetectable PSA concentrations and associated panhypopituitarism and summarize the clinical presentation and pertinent laboratory and radiologic findings. We review related literature and discuss possible mechanisms explaining the described association. Results: Four men with PSA values below the second percentile of a healthy population had hypopituitarism. In 3 men, low PSA concentrations were noted before large pituitary tumors were diagnosed. No man had headaches, visual problems, or other symptoms that were severe enough to prompt a search for tumor. All 4 patients had undetectable total testosterone levels. Luteinizing hormone and follicle-stimulating hormone levels were low to low-normal in 3 of the 4 patients. Baseline growth hormone level was low in 1 patient and undetectable in the other 3. The insulinlike growth factor 1 concentration was less than 73 ng/mL in each patient. Conclusions: We believe that the association of low PSA concentrations and hypopituitarism is not incidental and that the extremely low PSA values in this case series were a consequence of both gonadal and growth hormone deficiency. We suggest that low PSA is a marker of combined profound testosterone and growth hormone deficiency in men with panhypopituitarism. This marker is important because PSA is frequently measured during routine health care visits; a low concentration may be the first clue to the presence of hypopituitarism in an otherwise asymptomatic patient.

AB - Objective: To report the association of undetectable or very low prostate-specific antigen (PSA) concentrations with hypopituitarism. Methods: We present a case series of 4 patients with low or undetectable PSA concentrations and associated panhypopituitarism and summarize the clinical presentation and pertinent laboratory and radiologic findings. We review related literature and discuss possible mechanisms explaining the described association. Results: Four men with PSA values below the second percentile of a healthy population had hypopituitarism. In 3 men, low PSA concentrations were noted before large pituitary tumors were diagnosed. No man had headaches, visual problems, or other symptoms that were severe enough to prompt a search for tumor. All 4 patients had undetectable total testosterone levels. Luteinizing hormone and follicle-stimulating hormone levels were low to low-normal in 3 of the 4 patients. Baseline growth hormone level was low in 1 patient and undetectable in the other 3. The insulinlike growth factor 1 concentration was less than 73 ng/mL in each patient. Conclusions: We believe that the association of low PSA concentrations and hypopituitarism is not incidental and that the extremely low PSA values in this case series were a consequence of both gonadal and growth hormone deficiency. We suggest that low PSA is a marker of combined profound testosterone and growth hormone deficiency in men with panhypopituitarism. This marker is important because PSA is frequently measured during routine health care visits; a low concentration may be the first clue to the presence of hypopituitarism in an otherwise asymptomatic patient.

UR - http://www.scopus.com/inward/record.url?scp=58149399920&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58149399920&partnerID=8YFLogxK

M3 - Article

VL - 14

SP - 432

EP - 436

JO - Endocrine Practice

JF - Endocrine Practice

SN - 1530-891X

IS - 4

ER -